Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 50 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Nathan B.

Spain

USD 50 /hr

Experienced molecular virologist specialized in revision of scientific writing. Bilingual (Spanish/English).

Profile Summary

As a PhD in molecular virology with 13+ years of benchtop experience leading to 35 peer-reviewed articles, I know what makes a good paper. Let me help you improve yours today! English: native Spanish: advanced I can provide Spanish <-> English translation Extensive editing experience in the fields of virology, neurobiology and structural biology. I have personally worked with >40 distinct research groups from diverse cultural backgrounds (mainly from Spain and China), resulting in publication of more than 145 journal articles and grant applications. Served as ad-hoc reviewer for several top journals including Journal of General Virology, PLoS One, and Virus Research. Every step of my adult life has involved either the pursuit of learning or helping others to achieve their academic goals. My extensive background in basic science makes me uniquely suited to the revision of scientific writing, and it is something I really enjoy. I have a sharp critical eye when reading, and small mistakes seem to jump off the page.

Subject Matter Expertise

• ★ Microbiology
• ★ Molecular Virology
• ★ Scientific Proofreading & Editing
• ☆ Molecular Biology
• ☆ Peer Review
• ☆ Technical & Scientific Writing
• ☆ Science Communication

Services

• Writing
• Research

Writing Clinical Trial Documentation, Technical Writing, Copywriting, Newswriting

Research Market Research, Gap Analysis, Systematic Literature Review

Work Experience

Freelance Scientific Editor

NB Revisions

January 2015 - Present

Program Administrator, Office of Postdoctoral Affairs

Moffitt Cancer Center

September 2019 - January 2022

English Language Teacher and Mentor

Self employed

January 2015 - August 2019

JAE Postdoctoral Fellow

Universidad Autonoma de Madrid Centro de Biología Molecular Severo Ochoa

December 2011 - November 2014

Research Scientist

Virginia Polytechnic Institute and State University

March 2010 - November 2011

Postdoctoral Associate

Virginia Polytechnic Institute and State University

July 2008 - February 2010

Teaching Postdoctoral Fellow

James Madison University

August 2006 - June 2008

Graduate Research Assistant

Virginia Polytechnic Institute and State University

January 2002 - August 2006

Education

Ph.D. Molecular Virology (Veterinary Medical Sciences)

Virginia Polytechnic Institute and State University

January 2002 - August 2006

B.S. Biochemistry (College of Agriculture)

Virginia Polytechnic Institute and State University

August 1999 - December 2001

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

(2018). Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virus . BMC infectious diseases.

(2017). Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment . Journal of virology.

(2016). Real-time PCR-based infectivity assay for the titration of turkey hemorrhagic enteritis virus, an adenovirus, in live vaccines . Journal of virological methods.

(2016). A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs . Virology.

(2014). Increased replicative fitness can lead to decreased drug sensitivity of hepatitis C virus . Journal of virology.

(2014). Molecular basis of interferon resistance in hepatitis C virus . Current opinion in virology.

(2014). A live-attenuated and an inactivated chimeric porcine circovirus (PCV)1-2 vaccine are both effective at inducing a humoral immune response and reducing PCV2 viremia and intrauterine infection in female swine of breeding age . Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

(2013). Concurrent porcine circovirus type 2a (PCV2a) or PCV2b infection increases the rate of amino acid mutations of porcine reproductive and respiratory syndrome virus (PRRSV) during serial passages in pigs . Virus research.

(2013). Response of hepatitis C virus to long-term passage in the presence of alpha interferon: multiple mutations and a common phenotype . Journal of virology.

(2012). A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection . Vaccine.

(2012). Bordetella avium antibiotic resistance, novel enrichment culture, and antigenic characterization . Veterinary microbiology.

(2012). Co-infection of porcine dendritic cells with porcine circovirus type 2a (PCV2a) and genotype II porcine reproductive and respiratory syndrome virus (PRRSV) induces CD4(+)CD25(+)FoxP3(+) T cells in vitro . Veterinary microbiology.

(2012). Expression of human CD46 has no effect on porcine circovirus type 2 infection and shedding in the experimental pig model . Veterinary research communications.

(2012). ORF1 but not ORF2 dependent differences are important for in vitro replication of PCV2 in porcine alveolar macrophages singularly or coinfected with PRRSV . Veterinary microbiology.

(2012). Effect of porcine circovirus type 2a or 2b on infection kinetics and pathogenicity of two genetically divergent strains of porcine reproductive and respiratory syndrome virus in the conventional pig model . Veterinary microbiology.

(2012). Vaccination with inactivated or live-attenuated chimeric PCV1-2 results in decreased viremia in challenge-exposed pigs and may reduce transmission of PCV2 . Veterinary microbiology.

(2011). An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model . Microbiology and immunology.

(2011). Use of PCR-based assays for the detection of the adventitious agent porcine circovirus type 1 (PCV1) in vaccines, and for confirming the identity of cell substrates and viruses used in vaccine production . Journal of virological methods.

(2011). Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2) . Virus research.

(2011). Studies on porcine circovirus type 2 vaccination of 5-day-old piglets . Clinical and vaccine immunology : CVI.

(2011). Productive infection of human hepatocellular carcinoma cells by porcine circovirus type 1 . Vaccine.

(2011). A live-attenuated chimeric porcine circovirus type 2 (PCV2) vaccine is transmitted to contact pigs but is not upregulated by concurrent infection with porcine parvovirus (PPV) and porcine reproductive and respiratory syndrome virus (PRRSV) and is efficacious in a PCV2b-PRRSV-PPV challenge model . Clinical and vaccine immunology : CVI.

(2011). The autotransporter protein from Bordetella avium, Baa1, is involved in host cell attachment . Microbiological research.

(2011). Bordetella avium causes induction of apoptosis and nitric oxide synthase in turkey tracheal explant cultures . Microbes and infection.

(2011). Porcine reproductive and respiratory syndrome virus (PRRSV) influences infection dynamics of porcine circovirus type 2 (PCV2) subtypes PCV2a and PCV2b by prolonging PCV2 viremia and shedding . Veterinary microbiology.

(2011). Porcine circovirus type 2 (PCV2) vaccination is effective in reducing disease and PCV2 shedding in semen of boars concurrently infected with PCV2 and Mycoplasma hyopneumoniae . Theriogenology.

(2011). Three amino acid mutations (F51L, T59A, and S390L) in the capsid protein of the hepatitis E virus collectively contribute to virus attenuation . Journal of virology.

(2011). Expression of the putative ORF1 capsid protein of Torque teno sus virus 2 (TTSuV2) and development of Western blot and ELISA serodiagnostic assays: correlation between TTSuV2 viral load and IgG antibody level in pigs . Virus research.

(2011). Chimeric porcine circoviruses (PCV) containing amino acid epitope tags in the C terminus of the capsid gene are infectious and elicit both anti-epitope tag antibodies and anti-PCV type 2 neutralizing antibodies in pigs . Journal of virology.

(2010). Novel chimeric porcine circovirus (PCV) with the capsid gene of the emerging PCV2b subtype cloned in the genomic backbone of the non-pathogenic PCV1 is attenuated in vivo and induces protective and cross-protective immunity against PCV2b and PCV2a subtypes in pigs . Vaccine.

(2010). Porcine reproductive and respiratory syndrome virus infection at the time of porcine circovirus type 2 vaccination has no impact on vaccine efficacy . Clinical and vaccine immunology : CVI.

(2010). Comparison of commercial and experimental porcine circovirus type 2 (PCV2) vaccines using a triple challenge with PCV2, porcine reproductive and respiratory syndrome virus (PRRSV), and porcine parvovirus (PPV) . Vaccine.

(2010). Replacement of the replication factors of porcine circovirus (PCV) type 2 with those of PCV type 1 greatly enhances viral replication in vitro . Journal of virology.

(2009). Persistent infection of turkeys with an avirulent strain of turkey hemorrhagic enteritis virus . Avian diseases.

(2009). Comparison of 12 turkey hemorrhagic enteritis virus isolates allows prediction of genetic factors affecting virulence . The Journal of general virology.